Jared David Miller, MD
Cardiovascular Disease (Cardiology) · Murray
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Ihc Health Services Inc · 3,948 clinicians in this group
Hospitals listed: Intermountain Health Alta View Hospital · Intermountain Health Intermountain Medical Center · Intermountain Health Riverton Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Miller’s office at (801) 507-3513 to ask if they take your plan before you enroll.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Intermountain Health Alta View HospitalSandy, UTAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Intermountain Healthcare, which runs 33 hospitals in 4 statesPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsNo measure marked better or worse than the national rate
- Intermountain Health Riverton HospitalRiverton, UTAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Intermountain Healthcare, which runs 33 hospitals in 4 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsNo measure marked better or worse than the national rate
- Intermountain Medical CenterMurray, UTAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Intermountain Healthcare, which runs 33 hospitals in 4 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.537, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.503, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.345, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.259, Oct 2024 – Sep 2025
See every measure and the patient survey for Intermountain Health Alta View Hospital
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 2 better, 3 the same, 0 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.12) · 153 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.94 (0.45 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 54 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 856 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 907 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 878 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.31 (0.74 to 5.88) · 131 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.38) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.62 (0.9 to 4.34) · 120 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.92 (0 to 18.86) · 46 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.13 (0.83 to 9.43) · 46 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.28) · 41 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.51 (0 to 1.72) · 611 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.625 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.54 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.3 · 100 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -75.5 · 53 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -65.3 · 113 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.1 · 188 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.5) · 503 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 290 cases | No different | Jan 2024 – Dec 2024 |
What patients said (729 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 5 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 84% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 83% |
| Doctors "always" treated them with courtesy and respect | 91% |
| Patients who gave a rating of "9" or "10" (high) | 80% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 92% |
See every measure and the patient survey for Intermountain Health Riverton Hospital
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 2 better, 6 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0 to 2.11) · 145 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.94 (0.45 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 12 · 79 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.4 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 951 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 858 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.28 (0.72 to 5.84) · 149 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.67 (0 to 3.4) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.3 (0.58 to 4.02) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.12 (0 to 19.16) · 42 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.19 (0.87 to 9.51) · 35 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 34 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.5 (0 to 1.7) · 649 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 30 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.437 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.5 · 139 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -43.1 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -25.3 · 108 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 188 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.4 to 8.1) · 54 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7.3 to 15) · 54 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.9 to 17) · 918 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 168 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,083 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Intermountain Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 4 better, 6 the same, 0 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.537 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.503 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.345 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.259 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.77 (0 to 1.6) · 2,129 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.63 to 1.09) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.02 (125.43 to 206.62) · 185 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 84 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9 · 306 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.9 · 613 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 353 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.1 · 705 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 6,146 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0.02 to 0.38) · 8,688 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.07 to 0.44) · 9,038 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.19 (1.59 to 4.79) · 3,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.75 (0.56 to 2.94) · 1,281 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.38 (1.18 to 3.57) · 2,938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.14 (2.82 to 11.46) · 1,300 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.28 (0.68 to 5.88) · 1,387 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.3 (0 to 2.62) · 847 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.7 (0.2 to 1.19) · 7,132 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.672 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 11.7 · 551 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.1 · 1,150 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -46 · 370 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -63.9 · 697 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -48.4 · 365 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 14.6 · 646 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.3 (4.3 to 9.1) · 206 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9 (6.5 to 12.4) · 206 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 157 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.7 (9 to 15.3) · 1,438 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 770 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,383 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$173,417
Medicare paid this office $173,417 for 1,033 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 64 | $46,114 | $699 |
| Return visit (30+ min) | 223 | $27,008 | $92 |
| New patient visit (45+ min) | 115 | $13,677 | $119 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 37 | $13,645 | $369 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 13 | $8,688 | $621 |
See all 27 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 64 | $46,114 | $699 |
| Return visit (30+ min) | 223 | $27,008 | $92 |
| New patient visit (45+ min) | 115 | $13,677 | $119 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 37 | $13,645 | $369 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 13 | $8,688 | $621 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 145 | $6,614 | $18 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 195 | $6,279 | $13 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 15 | $3,397 | $226 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 14 | $3,184 | $227 |
| Programming of dual lead pacemaker system | 46 | $2,893 | $58 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 51 | $2,714 | $24 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 11 | $2,660 | $47 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 116 | $2,601 | $21 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 124 | $2,352 | $19 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 125 | $2,122 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 136 | $1,476 | $10 |
| Short return visit (20+ min) | 21 | $1,442 | $66 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 21 | $1,033 | $49 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 32 | $993 | $28 |
| Programming of multiple lead implantable defibrillator system | 12 | $944 | $79 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 112 | $763 | $6 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 17 | $664 | $39 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 49 | $650 | $13 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 33 | $484 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 35 | $301 | $9 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 17 | $221 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 20 | $116 | $6 |
Procedures Medicare counted
| Pacemaker insertion or repair | 50 | More than 89% of doctors who do this |
Who their Medicare patients are
1,033 Original Medicare patients in 2024. Average age 76 · Under 65 4% · 85 and older 16% · Women 47% · Also on Medicaid 6% · Health risk score 1.57. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Atrial fibrillation 57% · Coronary heart disease 47% · Heart failure 41% · Chronic kidney disease 37% · Diabetes 31% · Depression 26% · Cancer 16% · Stroke 15% · COPD 13% · Dementia 7%.
The office billed $653,348, Medicare allowed $225,174 and paid $173,417; for 2,683 services of 65 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,033 | 2,683 | 76 | 1.57 | $653,348 | $173,417 |
| 2023 | 965 | 2,375 | 76 | 1.73 | $526,834 | $146,741 |
| 2022 | 938 | 2,124 | 76 | 1.54 | $456,132 | $149,977 |
| 2021 | 974 | 2,254 | 75 | 1.61 | $517,346 | $169,411 |
| 2020 | 562 | 1,402 | 75 | 1.67 | $396,672 | $136,500 |
| 2019 | 2,927 | 4,600 | 71 | 2.13 | $320,678 | $90,925 |
| 2018 | 1,179 | 1,669 | 69 | 1.93 | $90,535 | $27,997 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 23 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 56 | $41,523 | $704 |
| Return visit (30+ min) | 180 | $21,954 | $92 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 29 | $11,097 | $383 |
| New patient visit (45+ min) | 75 | $9,126 | $122 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 178 | $6,488 | $15 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 132 | $6,375 | $20 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 17 | $4,171 | $232 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 47 | $3,134 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 286 | $2,954 | $10 |
| Programming of dual lead pacemaker system | 39 | $2,489 | $53 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 110 | $1,815 | $16 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 87 | $1,683 | $19 |
| Short return visit (20+ min) | 23 | $1,230 | $51 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 20 | $897 | $45 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 107 | $771 | $6 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 17 | $721 | $42 |
| Programming of single lead pacemaker system | 11 | $512 | $47 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 27 | $351 | $13 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 19 | $312 | $16 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 28 | $267 | $10 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $176 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 18 | $100 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $33 | $2 |
2022: 27 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 40 | $36,540 | $850 |
| Return visit (30+ min) | 135 | $15,080 | $95 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 21 | $13,067 | $622 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 29 | $10,933 | $377 |
| New patient visit (45+ min) | 88 | $10,365 | $118 |
| Short return visit (20+ min) | 134 | $8,823 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 393 | $4,788 | $10 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 128 | $3,450 | $15 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 14 | $3,253 | $217 |
| Programming of dual lead pacemaker system | 47 | $2,836 | $56 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 94 | $2,794 | $20 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 37 | $2,369 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 39 | $1,967 | $50 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 98 | $1,898 | $19 |
| Programming of dual lead implantable defibrillator system | 17 | $1,427 | $71 |
| New patient visit (30+ min) | 14 | $1,200 | $86 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 51 | $940 | $18 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $925 | $54 |
| Programming of multiple lead implantable defibrillator system | 11 | $851 | $71 |
| Programming of single lead pacemaker system | 14 | $766 | $48 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 16 | $754 | $47 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 86 | $612 | $6 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 32 | $421 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 20 | $249 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 29 | $184 | $6 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 18 | $184 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $43 | $2 |
2021: 33 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 31 | $27,968 | $874 |
| Return visit (30+ min) | 144 | $14,891 | $86 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 45 | $11,417 | $233 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 26 | $11,062 | $410 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 13 | $9,197 | $657 |
| Short return visit (20+ min) | 110 | $8,121 | $71 |
| Insertion of implantable defibrillator system | 11 | $7,648 | $695 |
| New patient visit (45+ min) | 53 | $6,578 | $124 |
| Programming of dual lead pacemaker system | 73 | $4,741 | $55 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 300 | $3,864 | $11 |
| Removal and replacement of dual lead permanent pacemaker | 14 | $3,586 | $256 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 120 | $3,462 | $18 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 32 | $2,929 | $89 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 143 | $2,806 | $20 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 89 | $2,752 | $22 |
| New patient visit (60+ min) | 16 | $2,457 | $154 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 35 | $2,116 | $29 |
| Long return visit (40+ min) | 14 | $2,009 | $134 |
| Programming of multiple lead implantable defibrillator system | 25 | $1,960 | $73 |
| Programming of heart rhythm stimulation after drug infusion | 18 | $1,767 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $1,408 | $56 |
| Programming of dual lead implantable defibrillator system | 18 | $1,400 | $61 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 14 | $1,383 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 24 | $1,207 | $48 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 168 | $1,174 | $6 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 16 | $817 | $51 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 44 | $625 | $14 |
| Programming of single lead pacemaker system | 11 | $506 | $42 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 41 | $433 | $10 |
| Ultrasound of heart blood flow, valves and chambers | 22 | $301 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 37 | $243 | $7 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 13 | $228 | $18 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 23 | $55 | $2 |
2020: 29 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 16 | $15,633 | $920 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 30 | $12,392 | $413 |
| Return visit (30+ min) | 114 | $11,437 | $84 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 15 | $10,230 | $682 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 33 | $8,257 | $243 |
| New patient visit (45+ min) | 59 | $7,244 | $123 |
| New patient visit (60+ min) | 33 | $5,304 | $161 |
| Programming of heart rhythm stimulation after drug infusion | 29 | $3,754 | $129 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 229 | $3,491 | $12 |
| Long return visit (40+ min) | 26 | $3,153 | $109 |
| Programming of dual lead pacemaker system | 42 | $2,383 | $50 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 18 | $2,185 | $115 |
| Short return visit (20+ min) | 41 | $2,174 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,071 | $58 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 91 | $1,897 | $20 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 16 | $1,531 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 20 | $1,230 | $59 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 51 | $1,227 | $19 |
| Programming of multiple lead implantable defibrillator system | 14 | $1,172 | $73 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 36 | $1,029 | $25 |
| Programming of single lead pacemaker system | 18 | $895 | $47 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 39 | $814 | $21 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 15 | $677 | $29 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 13 | $653 | $50 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 15 | $317 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 24 | $247 | $10 |
| Ultrasound of heart blood flow, valves and chambers | 14 | $183 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 26 | $124 | $4 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 15 | $36 | $2 |
2019: 16 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 2,696 | $25,831 | $6 |
| Insertion of implantable defibrillator system | 15 | $11,237 | $749 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 13 | $8,851 | $681 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 15 | $3,619 | $241 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $2,346 | $56 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 60 | $2,311 | $35 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,484 | $78 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,431 | $110 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 42 | $1,359 | $30 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 44 | $865 | $19 |
| Return visit (30+ min) | 11 | $762 | $63 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 28 | $671 | $24 |
| Programming of dual lead pacemaker system | 22 | $657 | $30 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 18 | $547 | $30 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 23 | $391 | $17 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 14 | $323 | $23 |
2018: 5 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,111 | $10,221 | $7 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 15 | $654 | $44 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 11 | $334 | $30 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 13 | $284 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 11 | $192 | $17 |
Medicaid work
$32 in 2022
Medicaid paid $32 for 15 billed services this clinician did in 2022, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 15 | $32 |
| 2022 | 15 | 1 | 13 | $32 |
| 2020 | 95 | 1 | 27 | $634 |
| 2019 | 4,856 | 1 | 417 | $21,796 |
| 2018 | 1,755 | 1 | 388 | $7,744 |
See the largest Medicaid services in earlier years
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 95 | $634 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 4,856 | $21,796 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,755 | $7,744 |
Drugs they prescribed that Part D paid
$566,084
Pharmacies billed $566,084 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
613 generic and 464 brand-name prescriptions · $566,084 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 351 | $434,327 | $1,237 |
| Xarelto | 104 | $112,271 | $1,080 |
| Flecainide Acetate | 143 | $6,447 | $45 |
| Metoprolol | 176 | $2,877 | $16 |
| Amiodarone | 121 | $1,762 | $15 |
See all 8 drugs
| Eliquis | 351 | $434,327 | $1,237 |
| Xarelto | 104 | $112,271 | $1,080 |
| Flecainide Acetate | 143 | $6,447 | $45 |
| Metoprolol | 176 | $2,877 | $16 |
| Amiodarone | 121 | $1,762 | $15 |
| Diltiazem 24hr Er (Cd) | 33 | $1,068 | $32 |
| Metoprolol | 35 | $323 | $9 |
| Carvedilol | 15 | $96 | $6 |
Year by year
| 2024 | 1,077 | 349 | None | 43% | $566,084 |
| 2023 | 836 | 314 | None | None | $365,617 |
| 2022 | 720 | 296 | None | 34% | $291,856 |
| 2021 | 529 | 199 | None | 28% | $171,128 |
| 2020 | 340 | 148 | None | 33% | $112,041 |
| 2019 | 61 | 22 | None | 43% | $16,679 |
| 2018 | 53 | 17 | 0% (0) | None | $2,226 |
| 2017 | 72 | 34 | 0% (0) | 24% | $6,745 |
| 2016 | 102 | 28 | 0% (0) | None | $7,188 |
| 2015 | 83 | 26 | 0% (0) | 33% | $9,432 |
| 2014 | 73 | 15 | 0% (0) | None | $3,650 |
| 2013 | 31 | None | 0% (0) | None | $2,875 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Eliquis | 225 | $265,926 | $1,182 |
| Xarelto | 61 | $73,489 | $1,205 |
| Flecainide Acetate | 132 | $10,260 | $78 |
| Metoprolol | 142 | $2,746 | $19 |
| Amiodarone | 88 | $1,569 | $18 |
| Diltiazem 24hr Er (Cd) | 15 | $1,470 | $98 |
| Sotalol | 17 | $376 | $22 |
| Metoprolol | 22 | $144 | $7 |
| Carvedilol | 17 | $125 | $7 |
2022: 8 drugs
| Eliquis | 184 | $209,278 | $1,137 |
| Xarelto | 50 | $54,509 | $1,090 |
| Flecainide Acetate | 128 | $11,025 | $86 |
| Amiodarone | 78 | $2,144 | $27 |
| Metoprolol | 126 | $1,966 | $16 |
| Diltiazem 24hr Er (Cd) | 20 | $1,867 | $93 |
| Sotalol | 28 | $652 | $23 |
| Metoprolol | 13 | $162 | $12 |
2021: 8 drugs
| Eliquis | 116 | $117,482 | $1,013 |
| Xarelto | 25 | $33,864 | $1,355 |
| Flecainide Acetate | 105 | $10,548 | $100 |
| Metoprolol | 118 | $2,313 | $20 |
| Amiodarone | 55 | $1,274 | $23 |
| Sotalol | 14 | $211 | $15 |
| Carvedilol | 11 | $139 | $13 |
| Metoprolol | 11 | $35 | $3 |
2020: 6 drugs
| Eliquis | 70 | $66,968 | $957 |
| Xarelto | 29 | $31,820 | $1,097 |
| Flecainide Acetate | 59 | $7,074 | $120 |
| Metoprolol | 73 | $1,730 | $24 |
| Amiodarone | 37 | $906 | $24 |
| Sotalol | 12 | $377 | $31 |
2019: 2 drugs
| Eliquis | 15 | $11,911 | $794 |
| Flecainide Acetate | 15 | $1,292 | $86 |
2018: 1 drug
| Clopidogrel | 12 | $219 | $18 |
2017: 1 drug
| Clopidogrel | 21 | $502 | $24 |
2016: 3 drugs
| Metoprolol | 16 | $607 | $38 |
| Pravastatin | 13 | $265 | $20 |
| Carvedilol | 22 | $77 | $4 |
2015: 1 drug
| Furosemide | 15 | $55 | $4 |
2014: 3 drugs
| Metoprolol | 13 | $1,087 | $84 |
| Spironolactone | 17 | $97 | $6 |
| Furosemide | 15 | $71 | $5 |
Money from drug and device companies
$164 in 2025
| 2025 | 2 | 9 | None | $164 |
| 2024 | 3 | 29 | None | $2,477 |
| 2023 | 1 | 13 | None | $521 |
| 2022 | 4 | 12 | None | $519 |
| 2021 | 2 | 6 | None | $243 |
| 2020 | 3 | 20 | None | $842 |
| 2019 | 4 | 31 | None | $3,304 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Gallant | $145 | 8 payments
|
| Medtronic | Micra | $19 | 1 payment
|
See all 9 published payments
| Abbott Laboratories | Meals · 2025-08-18 | Gallant | $27 |
| Abbott Laboratories | Meals · 2025-07-09 | Aveir | $13 |
| Medtronic | Meals · 2025-06-13 | Micra | $19 |
| Abbott Laboratories | Meals · 2025-05-22 | Ensite | $6 |
| Abbott Laboratories | Meals · 2025-05-12 | Gallant | $17 |
| Abbott Laboratories | Meals · 2025-05-01 | Aveir | $9 |
| Abbott Laboratories | Meals · 2025-05-01 | Jot Dx | $35 |
| Abbott Laboratories | Meals · 2025-03-10 | Gallant | $17 |
| Abbott Laboratories | Meals · 2025-03-10 | Aveir | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,477
| Medtronic | Pulseselect | $2,103 | 14 payments
|
| Abbott Laboratories | Gallant | $189 | 13 payments
|
| Boston Scientific | None | $184 | 2 payments
|
2023: $521
| Medtronic | Na | $521 | 13 payments
|
2022: $519
| Medtronic | Na | $335 | 9 payments
|
| CVRx | Barostim Neo System | $107 | 1 payment
|
| AtriCure | Synergy Ablation System | $54 | 1 payment
|
| Abbott Laboratories | Accent | $23 | 1 payment
|
2021: $243
| Medtronic | Reveal Linq | $163 | 5 payments
|
| Abbott Laboratories | Advisor Catheter | $80 | 1 payment
|
2020: $842
| Medtronic Vascular | Selectsecure | $369 | 5 payments
|
| Abbott Laboratories | Ensite Cardiac Mapping System | $301 | 12 payments
|
| Biosense Webster | Carto 3 System | $172 | 3 payments
|
2019: $3,304
| Abbott Laboratories | Ensite Cardiac Mapping System | $2,151 | 18 payments
|
| Boston Scientific | Sq Rx Pulse Generator | $912 | 8 payments
|
| Biosense Webster | Carto 3 System | $190 | 2 payments
|
| Medtronic Vascular | Selectsecure | $52 | 3 payments
|
Professional record
- NPI
- 1013293620
- Licence
- OR MD187656
- Trained
- Washington University School of Medicine, 2010
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Internal medicine (207R00000X); Cardiology (207RC0000X)
- Mailing address
- 5121 S Cottonwood St, Salt Lake City, UT, 84107
- NPI first listed
- 2011-10-26
- NPI last updated
- 2020-01-14
- NPI record certified
- 2020-01-14
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3303 Sw Bond Ave Ste 9, Portland, OR, 97239 · 300 Pasteur Dr Rm S101, Stanford, CA, 94305